Transcatheter Aortic Valve Implantation Management of risks and complications

Similar documents
Heart Team For TAVI Who and How?

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

Image Assistance in TAVI Why CT? Won-Jang Kim, MD, PhD Clinical Assistant Professor of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

TAVI complication. Possible aetiology and how to manage

Echo Assessment Pre-TAVI

Transcatheter Aortic Valve Implantation Present Status and Perspectives

Prince Sultan Cardiac Center Experience Riyadh, Saudi Arabia

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo

TAVR SPRING 2017 The evolution of TAVR

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root

Affiliation/Financial Relationship Grant/ Research Support: Major Stock Shareholder/Equity Interest: Royalty Income: Ownership/Founder: Salary:

TAVI IN BICUSPID AOV AND VALVE-IN-VALVE

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

SAPIEN 3 Sizing Considerations:

The Role of Imaging in Transcatheter Aortic Valve Implantation

An Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.

Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland

How to manage TAVI related vascular complications. Paul TL Chiam MBBS, FRCP, FESC, FACC, FSCAI

1-YEAR OUTCOMES FROM JOHN WEBB, MD

Pre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

Evolut R in bicuspid valve anatomies

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Results of Transapical Valves. A.P. Kappetein Dept Cardio-thoracic surgery

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40

22/06/2017. Oxford City. Transcatheter aortic valve replacement 2017 guidelines. 1. First time I have heard about it. 2.

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC

(EU), FACC (USA), FSCAI (USA)

Procedural Guidance of TAVR: How to Assure it Goes Right and What to Do If It Doesn t

TAVI at Liverpool Heart & Chest Hospital. National Audit of Cardiac Services in Wales Wrexham 28/11/2012

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?

Alternate Vascular Access for TAVR. Gian Paolo Ussia Campus Bio-medico University, Rome Italy

Dr Winnie Sze-Wun Chan. Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes

Optimal Imaging Technique Prior to TAVI -Echocardiography-

Case Presentations TAVR: The Good Bad and The Ugly

AORTIC AND MITRAL VALVE DISEASE HEMODYNAMICS AND CLINICAL ASPECTS

Transcatheter aortic valve implantation for severe aortic valve stenosis with the ACURATE neo2 valve system: 30-day safety and performance outcomes

TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis

Chapter 10: Step-by-step guide: Transfemoral Sapien S3 TAVR Omar F. Hadidi, MD, Tom C. Nguyen, MD UT Houston. Essential or Key Steps

First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.

TAVI Post operative Care. Why? Indications: Suzanne Beichner BSN, RN, PCCN Angela Robinson MSN, RN, CCRN, CVRN

Conflicts of interests

TAVI: Present and Future Perspective

Conflicts of interests

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center

The Transcatheter Aortic Valve Replacement (TAVR)Program at Southcoast Health. Adam J. Saltzman, MD Cardiovascular Care Center

2 Brigham and Women s Hospital, Boston, MA.

Menachem M. Weiner Assistant Professor of Anesthesiology Icahn School of Medicine at Mount Sinai

Transcatheter Aortic Valve Replacement TAVR

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

Echo evaluation for TAVR. From the General Cardiologist to the Interventional Echocardiologist

Percutaneous Therapy for Calcific Mitral Valve Disease

Transcatheter Aortic Valve Replacement

Structural Heart Disease Transcatheter Aortic Valve Replacement (TAVR)

Challenging Case. 89 year old man 5/11/2016. Prior 31 mm CoreValve NYHA III Moderately-severe PVL

*Core lab for numerous trials, for which I receive no direct compensation from sponsors.

Prevention and Management of Vascular Complications Related to Transcatheter Aortic Valve Implantation

TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre

Jonathon Leipsic MD FRCPC FSCCT. Vice Chairman of Radiology University of British Columbia. Disclosures

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

Percutaneous Aortic Valve Implantation. Core-Valve and Cribier-Edwards Update

Optimal Techniques for Obtaining Large Caliber Arterial Access

VALVULAR HEART DISEASE AORTIC VALVE STENOSIS TAVR PROCEDURE

A review of the complications associated with Transcatheter Aortic Valve Implantation.

TAVR: Echo Measurements Pre, Post And Intra Procedure

Section 1: Initial Evaluation for Valvular Heart Disease Table 1: Initial Evaluation of an Asymptomatic Patient

Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update

Aortic Valve Implantation

TAVR: It s a Career, Not Just a Procedure! Jeffrey A Southard, MD Cardiology May 5, 2012

A new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center

Potential conflicts of interest

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON

Bifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully

Emergency TAVI: Does It Exist? Is the Risk Higher?

Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,

Stainless Steel. Cobalt-chromium

Important Safety Information

Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

CoreValve in a Degenerative Surgical Valve

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

Preprocedural evaluation for TAVR

TAVI Implantation: Rapid Pacing, Pre and Post Dilatation

TAVI in Korea, How to Avoid Conduction

Transcatheter aortic valve implantation and pre-procedural risk assesment

DISCLOSURE. Relevant Financial Relationship(s) Off Label Usage. None. None

The Future of Medicine. Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy

Aortic Valve Stenosis and TAVR: Putting it all together.

Transcatheter Aortic Valve Implantation Anaesthetic Prespectives

Portico (St. Jude Medical Inc, St.

From Dream to Reality. The PVT Story

Joseph E. Bavaria, M.D. Roberts Measy Professor and Vice Chief CardioVascular Surgery Director: Thoracic Aortic Surgery Program University of

PVL Assessment. Is paravalvular regurgitation after TAVR still an important consideration in 2018?

Transcription:

Transcatheter Aortic Valve Implantation Management of risks and complications TAVI Summit, Seoul, Korea, Spetember 3rd, 2011 Alain Cribier University of Rouen, France

Complications of TAVI Depending on valve model, approach, and definition used (VARC?) -Vascular complications 3 to 22% -Stroke 0 to 7% -AMI <2% -Tamponade < 2.5% -Bleeding 3 to 25% -Paravalvular AR > 2 < 4% -PM 3 to 30% -THV embolization 1 to 2% - Aortic rupture/dissection < 2% Most complications can be avoided by a careful pre-procedural screening and can be prevented during the procedural phase (learning curve) Early detection of complications during the procedurerequest an urgent and adapted management

Prevention of complications 1) Screening phase

Patient selection Clinical indications & Relative contra-indications All bad candidates for AVR are not good candidates for TAVI -Life expectancy compromized (comorbidities) -Low LVEF with no contractility reserve -Bulging septum intraventricular gradient Prevention of risks -Supra-valvular calcified stenosis and complications -Severely calcified bicuspid valve -Low LM insertion and no dilated sinus -Bulky calcified leaflets -Specific contra-indications to TA approach

Valve sizing Prevention of THV embolization, paravalvular AR or aortic rupture SAPIEN and SAPIEN XT Annulus diameter 16mm 17mm 18mm 19mm 20mm 21mm 22mm 23mm 24mm 25mm 26mm 27mm ANNULUS - 18-21mm THV 23mm - 21-25mm THV 26mm - > 25mm THV 29mm 23 or 26mm? 26 or 29mm?

Any progress in annulus sizing? No gold standard technique P TEE (+ 1mm) D2 Severity and distribution of calcium on A the annulus circumference D1 are not taken into account TTE CT scan (+3mm)

Dynamic sizing by aortography per-bav Aortogram during 23mm balloon inflation Balloon size = annulus size, Balloon size < annulus size no AR AR + 23mm THV confirmed 26mm THV confirmed

Prevention of THV embolization paravalvular AR or aortic rupture Valve anatomy calcium distribution, calcific nodules: TTE,TEE, CT Bulky leaflets may be a contra-indication to TAVI Tricuspid or bicuspid valve?

Prevention of coronary occlusion CT-Scan - Distance Ostium-Annulus - Dilated or not dilated sinus? 12.1mm 8.3mm Ostia-LM should be > 10mm RCA LM

Prevention of coronary occlusion Aortogram during pre-dilatation

Prevention of vascular complications CT Scan Minimal internal diameters BASIC GUIDELINES NOVAFLEX - Use non-contrast imaging to better assess calcification - Measure 10.6mm the actual 11.8mm internal vessel diameters Minimal arterial sizes Calcifications 18F 7.5mm 7.5mm 19F R Grade 0 7.9mm 8.5mm 6mm 6.5mm Grade 1 6.5mm 6.40 mm 7mm Grade 2 8.20 mm 7mm 7.5mm L 7.6mm 7.7mm Grade 3 (circonf) 7.5mm 8mm Lumen view 8.23mm

Prevention of complications 2) Per-procedure

Prevention of THV migration RVP Mid-part of the RV posterior wall 200 or 220 bpm, 180 bpm acceptable 150 bpm in case of severe LV depression Loss of Capture 2/1 Capture

Prevention of THV migration Aortography: reference view LAO 10 Cranial 20 50 to 60% in LV LAO 10 Caudal 10 Do aortogram during RVP

Valve delivery Sheath at the level of the double marker on novaflex (stability) Holding the balloon fully inflated 5 sec decreases recoil and paravalvular AR The full quantity of contrast must be administered Final valve size is volume dependent!

Management of Complications Vascular complications Never remove the sheath without contra-lateral contrast injection Have all type/sizes of occlusion balloons, covered and non-covered stent available Consider femoral repair Critical to be prepared to deal with femoro-iliac complications

Iliac/femoral rupture after sheath removal (same patient) COVERED STENT

Iliac/femoral rupture after sheath removal (Rouen) Super Arrow-Flex sheath 10F from LFA Vascular Stent Graft Fluency Plus 13.5 / 40m (BARD)

Complications Rupture of the annulus Higher risk in case of porcelain aorta and angulated aorta Almost always related to balloon or valve oversizing: Prefer smaller size in heavily calcific valve, porcelain aorta, extremely old patients

Rupture of the annulus by valve oversizing Annulus 20.5mm on TTE: 25 mm THV, 90y-old woman Rupture of the annulus at the low border of the stent + Pericardial tamponade

Rupture of the annulus Annulus 21.5 on TTE, 25 mm THV 90y-old woman: VALVE-IN-VALVE

Rupture of the annulus Annulus 21.5 on TTE, 25 mm THV 90y-old woman

Complications Valve embolization TECHNICAL ERROR THV positioned too high Valve not inflated fully Pacing stopped prematurely or lack of capture Under THV sizing or annulus too large THV positioned too ventricular BULGING SEPTUM

Explanation: loss of capture during RVP

THV Deployed In Distal Aorta

Bulging septum: Transapical case

Bulging septum: Transapical case

Bulging septum: Transapical case

Valve embolization: LV - Aortogram post reveals severe AI secondary to valve being too low - Valve embolized into LV

Complications Valve malpositioning

Valve in Valve for Malpositioning During deployment, valve migrated cranially Valve is clearly above annulus and not in stable position

Valve in Valve for Malpositioning Second valve positioned inferiorly and deployed to secure the first valve and correct paravalvular leak

Valve in Valve for malpositioning

Complications Left main occlusion

Left Main Occlusion Preventive wiring of the LAD for urgent post-thv delivery stenting has been done but LM stenting can be successfully achieved in only 50% of the cases. Never hesitate to decline TAVI! THV deployment led to left main occlusion by calcific native aortic valve leaflet

Conclusions - In spite of optimal training and proctoring programs, the learning curve for TF-TVAI is permanent, on a case after case basis - The success and safety of the procedures rely on the respect of protocols and recommendations. Each step is a succession of important details. Each omission may be life threatening - An optimal partnership within the team is crucial for both patient selection and procedure